The way I see this is simple: Current share price doesn't...

The way I see this is simple:

Current share price doesn't reflect the current development of science we own. Many valuations are saying $31.00+

If you add another rare disease to the mix, this valuation will increase the new valuation.

If you add in 3 more positive breakthroughs, the share valuation would be in excess of $100.00.

So, if the current share price is $22.57, there is certainly only extreme upside. We are trading in profit, we expect these profits to grow exponentially and with new disease being treated, the current share price has a very long way to go, to get to a point of stabilisation.

For me, it's one of the most simple stock picks around to generate further profits.

xoxo

Merry Christmas all.